Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Harper Hubbeling"'
Autor:
Satoshi Yoda, Wafa Malik, Adam Langenbucher, Justin F. Gainor, Sai-Hong Ignatius Ou, Kylie Prutisto-Chang, Ramin Sakhtemani, Jennifer L Peterson, Aaron N. Hata, Alexander Drilon, Andrew Do, Jessica J. Lin, Adam J. Schoenfeld, Viola W. Zhu, Ted William Johnson, Jochen K. Lennerz, Lecia V. Sequist, Noura J. Choudhury, Ibiayi Dagogo-Jack, Subba R. Digumarthy, Christina Falcon, Charlotte E. Lee, Alice T. Shaw, Michael S. Lawrence, Beow Y. Yeap, Jennifer S. Temel, Harper Hubbeling
Publikováno v:
Clin Cancer Res
Purpose: Current standard initial therapy for advanced, ROS proto-oncogene 1, receptor tyrosine kinase fusion (ROS1)-positive (ROS1+) non–small cell lung cancer (NSCLC) is crizotinib or entrectinib. Lorlatinib, a next-generation anaplastic lymphoma
Autor:
Abraham J. Wu, V. Rusch, Andreas Rimner, Bernard J. Park, Harper Hubbeling, E. Ziv, Charles B. Simone, Daniel R. Gomez, Christina Falcon, Annemarie F. Shepherd, A. Drilon, Daphna Y. Gelblum, Narek Shaverdian, Noura J. Choudhury
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e438-e439
Purpose/Objective(s) Local therapy (LTX) prolongs progression-free and overall survival (OS) in patients with oligometastatic non-small cell lung cancer. We previously reported substantial LTX benefit in time to progression or next therapy (TTP/TTNT)
Autor:
Sean McBride, Morgan E Freret, Kimberly Bundick, Mini Kamboj, Harper Hubbeling, Daniel R. Gomez, Oren Cahlon, Leslie A. Modlin
BackgroundIn an attempt to reduce interruptions in radiation treatment, our department implemented universal SARS-CoV-2 PCR testing during the peak of the New York City COVID-19 epidemic.MethodsStarting 4/18/20, outpatients coming into the Department
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7810ee584b2629260f78f47178631a3a
https://doi.org/10.1101/2020.08.11.20172551
https://doi.org/10.1101/2020.08.11.20172551
Autor:
William A. Mehan, Justin F. Gainor, Alice T. Shaw, Kevin S. Oh, Beow Y. Yeap, Helen A. Shih, Emily Schapira, Harper Hubbeling
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 101:624-629
Purpose Despite the emerging role of programmed cell death-1 (PD-1) pathway inhibitors for patients with advanced lung cancer, a paucity of data are available on the activity of these agents among patients with brain metastases. We investigated the o
Autor:
Justin F. Gainor, William A. Mehan, Emily Schapira, Alice T. Shaw, Jessica J. Lin, Kelly Goodwin, Nora Horick, Kevin S. Oh, Helen A. Shih, Harper Hubbeling
Publikováno v:
Journal of Thoracic Oncology. 13:550-558
Introduction Intracranial metastases are a common cause of morbidity and mortality in patients with advanced NSCLC, and are frequently managed with radiation therapy (RT). The safety of cranial RT in the setting of treatment with immune checkpoint in
Autor:
James S. Hardwick, Alice T. Shaw, Anna F. Farago, Aaron N. Hata, Lorin A. Ferris, Diane Tseng, Katherine Schultz, Beow Y. Yeap, Luc Friboulet, Justin F. Gainor, Satoshi Yoda, Donghui Huang, Leila Dardaei, Zofia Piotrowska, Ibiayi Dagogo-Jack, A. John Iafrate, Jessica J. Lin, Harper Hubbeling, Mari Mino-Kenudson
Publikováno v:
JCO Precision Oncology. :1-13
Purpose The ROS1 tyrosine kinase is activated through ROS1 gene rearrangements in 1% to 2% of non–small-cell lung cancers (NSCLCs), which confer sensitivity to treatment with the anaplastic lymphoma kinase (ALK)/ROS1/mesenchymal-epithelial transiti
Autor:
Andrzej Niemierko, Justin F. Gainor, William L. Hwang, Emily Schapira, Katie L. Hwang, Florence K. Keane, Harper Hubbeling
Publikováno v:
JAMA oncology. 4(2)
This cohort study evaluates the clinical outcomes in patients with metastatic lung cancer treated with PD-1/PD-L1 inhibitors and thoracic radiotherapy.
Autor:
Kevin S. Oh, Harper Hubbeling, Alice T. Shaw, Helen A. Shih, Justin F. Gainor, Emily Schapira
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 99:S150-S151
Autor:
Harper Hubbeling, Helen A. Shih, Kevin S. Oh, Justin F. Gainor, Alice T. Shaw, Emily Schapira
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 99:S210